The final, formatted version of the article will be published soon.
CASE REPORT article
Front. Oncol.
Sec. Gastrointestinal Cancers: Colorectal Cancer
Volume 14 - 2024 |
doi: 10.3389/fonc.2024.1391393
This article is part of the Research Topic Management of Rare Oncological Cases View all 56 articles
Receptor-inconsistent breast cancer metastases to the colon: a case report and review of the literature
Provisionally accepted- The First People's Hospital of Honghe, Mengzi City, China
The metastasis of breast cancer to the colon is a rare occurrence, especially in the presence of changes in estrogen and progesterone receptors. To date, literature has only reported two cases of invasive ductal carcinoma and two cases of invasive lobular carcinoma metastasizing to the colon with concurrent changes in hormone receptors. This report describes a 65-year-old female with a history of left breast cancer, who presented with symptoms of bloody stools and abdominal pain. CT and colonoscopy revealed a malignant tumor in the ascending colon, and the patient underwent surgery. Pathological results post-surgery indicated changes in hormone receptors, differing from the previous breast cancer pathology, ultimately leading to the diagnosis of breast cancer metastasis to the colon. The patient was found to have liver metastasis 14 months after right hemicolectomy, and systemic metastases in various locations were discovered at the 19-month mark.
Keywords: Colon metastasis, Progesterone Receptor, estrogen receptor, Non-specific types of breast cancer, breast cancer
Received: 22 Apr 2024; Accepted: 27 Dec 2024.
Copyright: © 2024 li, yang, you, sun, liu, Gao and xie. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
* Correspondence:
huimeng li, The First People's Hospital of Honghe, Mengzi City, 661100, China
liying yang, The First People's Hospital of Honghe, Mengzi City, 661100, China
baogan you, The First People's Hospital of Honghe, Mengzi City, 661100, China
xiqiang sun, The First People's Hospital of Honghe, Mengzi City, 661100, China
gongwu liu, The First People's Hospital of Honghe, Mengzi City, 661100, China
Weiwei Gao, The First People's Hospital of Honghe, Mengzi City, 661100, China
fengming xie, The First People's Hospital of Honghe, Mengzi City, 661100, China
Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.